Xcell Therapeutics
Latest round
- Series C
Last raised
- Mar 2021
Total raised
- $24M
Investors
- 15
About Xcell Therapeutics
Based in Seoul, South Korea, founded in 2015, Xcell Therapeutics Inc. trading under the name Xcell Therapeutics, operates as a company that specializes in creating new treatments for cancer and other diseases. The company focuses on drug discovery and development using cutting-edge technologies in the pharmaceutical industry.
Who invested in Xcell Therapeutics
15 investors across 3 rounds
See all investors in Xcell Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Xcell Therapeutics
Who invested in Xcell Therapeutics?
Xcell Therapeutics has 15 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Xcell Therapeutics raised?
Xcell Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Xcell Therapeutics last raise money?
Xcell Therapeutics's most recent round on record is a Series C, in Mar 2021.
What does Xcell Therapeutics do?
Based in Seoul, South Korea, founded in 2015, Xcell Therapeutics Inc.
Where is Xcell Therapeutics headquartered?
Xcell Therapeutics is headquartered in Seoul, South Korea.
Which VCs invest in companies like Xcell Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Xcell Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Xcell Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.